Celularity Inc. (GXGX) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Celularity Inc.

    NASDAQ: GXGX · Real-Time Price · USD
    10.20
    2.18 (27.18%)
    At close: Jul 19, 2021, 6:00 AM

    Celularity Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023
    Period Ending Dec 31, 2024 Dec 31, 2023
    Revenue
    		 54.22M 22.77M
    Cost of Revenue
    		 8.89M n/a
    Gross Profit
    		 45.33M n/a
    Operating Income
    		 -38.36M -192.29M
    Interest Income
    		 331K 320K
    Pretax Income
    		 -57.89M -196.28M
    Net Income
    		 -57.89M -196.29M
    Selling & General & Admin
    		 58.64M 50.58M
    Research & Development
    		 17.39M 30.46M
    Other Expenses
    		 7.66M 134.02M
    Operating Expenses
    		 83.69M 215.06M
    Interest Expense
    		 -6.26M -3.02M
    Selling & Marketing Expenses
    		 n/a n/a
    Cost & Expenses
    		 92.58M n/a
    Income Tax Expense
    		 n/a 10K
    Shares Outstanding (Basic)
    		 21.89M 188.32M
    Shares Outstanding (Diluted)
    		 21.89M 188.32M
    EPS (Basic)
    		 -2.64 -11.02
    EPS (Diluted)
    		 -2.64 -11.02
    EBITDA
    		 -38.36M -192.29M
    EBIT
    		 n/a n/a
    Depreciation & Amortization
    		 n/a n/a

    Add to Watchlist